Related Experiment Videos
Cholestasis induced hyperthyroidism after liver transplantation
1Department of Gastroenterology, Technical University of Munich, Germany.
Digestion
|January 1, 1995
Summary
Post-liver transplant, a woman developed hyperthyroidism and cholestasis. Treatment with methimazole and thyroidectomy resolved these conditions, indicating a link between thyroid function and liver health.
Area of Science:
- Hepatology
- Endocrinology
- Transplantation Medicine
Background:
- Liver transplantation is a critical treatment for end-stage liver disease, such as hepatitis-C-induced cirrhosis.
- Post-transplant complications can significantly impact patient outcomes and require careful management.
- Thyroid dysfunction is a known potential complication following major surgery and transplantation.
Observation:
- A 68-year-old woman developed hyperthyroidism and cholestatic jaundice after liver transplantation.
- Hepatic biopsies showed intrahepatic cholestasis and inflammation but no signs of rejection or hepatitis recurrence.
- The patient's symptoms improved with methimazole and normalized after subtotal thyroidectomy.
Findings:
- The study suggests a potential link between iodine-induced hyperthyroidism and cholestasis in liver transplant recipients.
- Methimazole treatment demonstrated a significant reduction in cholestasis markers.
- Normalization of thyroid function correlated with the recovery of liver function.
Implications:
- This case highlights the importance of monitoring thyroid function in liver transplant patients.
- It suggests that thyroid dysfunction may contribute to or exacerbate cholestasis post-transplantation.
- Further research is warranted to elucidate the mechanisms and clinical implications of this association.